The Impact of SARS-COV-2 Variants on Vaccine Efficacy Amongst Healthcare Workers During India’s Second Wave
Abstract Despite a growing sense of normalcy in many Western nations, another wave of the COVID-19 pandemic has spread rapidly through the Indian subcontinent.To improve our understanding of the crisis in India and the impact it is having on healthcare workers, we administered an electronic poll to healthcare workers in India.A total of 199 healthcare workers responded to the survey, the majority of whom were physicians. Of all respondents, 177 had received at least one dose of a COVID-19 vaccine. Of those vaccinated, 14 respondents (7.9%) received the Covaxin® (Bharat Biotech) vaccine, while the remaining 163 respondents (92.1%) received the Covishield® (Oxford-AstraZeneca) vaccine. Of the 177 respondents who received a dose of a COVID-19 vaccine, 76 (43%) acquired COVID-19 after vaccination, of which 88% had symptomatic infections. The protection offered by vaccination against new strains of SARS-CoV2 is a central question to which there remains an unclear answer.No external sources of funding were used.